SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is a hot topic as investors eye upcoming institutional ownership filings and a major industry conference, fueled by recent large capital raises that signal smart money conviction in its award-winning optical interposer technology for AI data centers, yet balanced by persistent community debate over management communication and revenue progress.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending sharply lower following an earnings report that featured a cut to its near-term profit guidance, overshadowing stronger revenue and leading to widespread debate among investors. The community is split, with some viewing the cybersecurity giant as overvalued amid M&A integration costs and AI disruption fears, while others see a prime long-term buying opportunity.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is drawing significant attention following new multi-million dollar contracts, including a deal for its Iron Drone Raider in a NATO country and counter-UAS solutions for German State Police. The community views these strategic wins as strong validation for Ondas's expanding autonomous defense systems in a rapidly growing sector, despite broader market volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as significant institutional buying, notably by Cormorant Asset Management, indicates strong conviction after previous selling. This activity precedes an eagerly anticipated Investor Day for major updates on its 'best in class' sonelokimab, fueling community discussion around potential undervaluation and persistent buyout speculation.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is a focal point of discussion due to a recent short report alleging unvetted contract workers and controversy over NYC tipping laws, sparking strong community debate on its long-term viability and consumer spending trends, even as analysts issue multiple upgrades and insiders show confidence.

WorldFinancial

WLFI is trending due to strong anticipation for a major convention hosted at Mar-a-Lago, where significant announcements regarding institutional adoption and the future of finance are expected. This optimism is met with intense debate and skepticism across the community following a Congressional probe into its foreign investment ties and potential conflicts of interest.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings (VRT) is seeing significant discussion and price action following strong quarterly results that highlighted explosive organic order growth and a record backlog, driven by surging demand for AI data center infrastructure. The company's robust outlook for the upcoming year and a wave of analyst upgrades are fueling optimism, with the community actively debating its critical role in the AI buildout and viewing recent pullbacks as buying opportunities despite high valuations.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending following strong earnings and an optimistic revenue forecast for 2026, significantly boosted by the escalating demand for off-grid power in the AI data center sector. The community is actively discussing its valuation amidst numerous analyst price target increases and a substantial product backlog, while also navigating broader market volatility.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending due to an expanded, multi-year partnership with Nvidia for advanced AI infrastructure and significant new positions disclosed by major institutional investors. The community is actively discussing both bullish excitement for Meta's AI future and lingering concerns about the impact of substantial capital expenditures.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is a trending topic as its upcoming Q4 earnings report draws investor attention, with strong performance in e-commerce and advertising driven by AI integration sparking debate over its high valuation compared to traditional retail metrics. The community is divided between bullish sentiment for its growth catalysts and concerns about whether the stock is overextended as a defensive play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN...

Lipocine Inc. (NASDAQ:LPCN) Short Interest Update

Lipocine Inc. (NASDAQ:LPCN - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 157,602 shares...

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Reports Encouraging Progress Post Second Interim Safety...

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone PR Newswire SALT LAKE CITY, Dec. 16, 2025 Second Drug...

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in...

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates

Lipocine (LPCN) delivered earnings and revenue surprises of -5.36% and +15.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 PR Newswire SALT LAKE CITY...

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek PR Newswire SALT LAKE CITY, Nov. 4, 2025 SALT LAKE CITY, Nov. 4, 2025 /PRNewswire...

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

LPCN
Lipocine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LPCN News

LPCNLipocine Inc